Harvard Bioscience Balance Sheet - Annual (NASDAQ:HBIO)

Add to My Stocks
$5.1 $0.05 (0.97%) HBIO stock closing price Jul 17, 2018 (Closing)

The Harvard Bioscience balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Harvard Bioscience stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Harvard Bioscience revenue Harvard Bioscience operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Harvard Bioscience balance sheet for 2017 shows cash on hand of $5.73M. The company has a debt to equity ratio of 0.79.

View latest 10 year balance sheet data to check Harvard Bioscience financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Cash5.73M5.59M6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M
Marketable Securities----------
Receivables20.44M19.92M21.42M20.88M17.65M18.97M17.57M17.58M16.63M17.55M
Inventory21.35M19.95M22.34M20.53M15.77M17.76M18.16M15.83M14.4M11.9M
Raw Materials10.02M9.79M10.49M9.44M7.98M9M9.16M8.06M6.73M7.15M
Work In Progress1.04M---------
Finished Goods10.28M9.34M10.95M10.13M7.03M8.02M8.37M7.17M7.11M3.97M
Notes Receivable----------
Other Current Assets---1.51M1.54M1.55M3.9M5.44M--
Total Current Assets
47.53M45.47M50.54M57.06M60.75M58.97M57.56M58.56M48.19M43.46M
Property Plant & Equipment20.49M18.9M21.92M20.2M18.82M17.86M13.38M13.15M12.7M11.37M
Accumulated Depreciation16.35M14.6M16.01M15.01M14.44M13.31M10.29M10M9.15M8.14M
Net Property Plant & Equipment
4.14M4.29M5.9M5.19M4.37M4.55M3.08M3.14M3.54M3.22M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges-1.15M-11.05M13.11M10.77M7.92M6.12M--
Intangibles57.17M56.71M62.45M62.22M56.9M58.7M57.84M56.6M54.51M33.78M
Deposits & Other Assets----------
Total Assets
109.35M107.76M120.21M135.91M135.46M133.48M126.63M124.79M107.23M81.27M
Notes Payable---------1.36M
Accounts Payable5.4M6.19M8.78M6.29M4.68M4.68M4.95M4.92M4.85M4.66M
Current Portion Long-Term Debt2.76M2.37M2.45M5M5M-----
Current Portion Capital Leases----------
Accrued Expenses4.93M4.77M4.31M5M5.17M4.01M3.57M5.27M4.04M4.43M
Income Taxes Payable--2.24M-------
Other Current Liabilities-1.26M1.62M1.67M1.22M1.21M1.02M1.1M3.34M-
Total Current Liabilities
14.04M14.6M19.4M18.09M16.08M9.9M9.55M11.29M12.25M11.21M
Mortgages----------
Deferred Taxes/Income3.96M6.41M3.77M1.32M----2.03M1.21M
Convertible Debt----------
Long-Term Debt8.98M11.37M16.45M16.45M19.75M12.95M16.3M18M13.3M-
Non-Current Capital Leases----------
Other Long-Term Liabilities1.46M3.17M2.98M4.57M4.98M6.14M4.9M4.29M4.37M2.06M
Total Liabilities
28.45M35.56M42.61M40.44M40.97M29.27M31.13M34.54M31.97M14.55M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus218.79M215.13M211.45M206.65M202.44M196.63M191.15M187.89M184.85M182.07M
Retained Earnings-116.96M-116.03M-111.72M-92.68M-95.03M-77.26M-79.63M-83.44M-102.45M-109.69M
Treasury Stock10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M5.66M3.26M
Other Liabilities-10.67M-16.65M-11.88M-8.23M-2.64M-4.86M-5.72M-3.89M-1.83M-2.75M
Shareholders Equity80.9M72.19M77.59M95.46M94.48M104.21M95.49M90.24M75.25M66.71M
Total Liabilities & Shareholders Equity109.35M107.76M120.21M135.91M135.46M133.48M126.63M124.79M107.23M81.27M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Harvard Bioscience historical stock prices and the current Harvard Bioscience stock price can tell you how the stock price has moved, whereas the Harvard Bioscience PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Harvard Bioscience company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Harvard Bioscience had total assets of $109.35M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. HBIO stock had total liabilities of $28.45M for the year 2017.

Harvard Bioscience Balance Sheet - Key Ratios

Current ratio
2.51
Debt to equity ratio
0.79
Asset turnover ratio
0.76
Receivables turnover
5.05
Price to book ratio
2.37